Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. NVDA
9. GO
10. ARX

Go back to Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial
(NASDAQ: HOTH) Delayed: 1.36 --0 (-0%)
Previous Close $1.36    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.36    P/E N/A 
Day Low $1.36    EPS $ 
Volume 7,031,267